Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrindependent microcirculation disorders.

摘要

A method of treatment of fibrin-dependent microcirculation disorders is disclosed, for example microcirculation disorders caused by metabolic diseases, inflammatory reactions or autoimmune diseases, which method comprises administering to a person in need of such treatment an effective amount of a pharmaceutical composition containing a pyrimido-pyrimidine selected from dipyridamole, mopidamol and the pharmaceutically acceptable salts thereof, and the use of said pyrimido-pyrimidine for the manufacture of a corresponding pharmaceutical composition.